TESTIS-SPECIFIC HUMAN SVPH1-8 PROTEINASE

(19)

(11)

EP 1 045 914 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	14.06.2006 Bulletin 2006/24

(45)	Mention of the grant of the patent:
	15.03.2006 Bulletin 2006/11

(21)	Application number: 99902177.7

(22)	Date of filing: 12.01.1999

(51)

International Patent Classification (IPC):

C12N 15/57^(2006.01)
C07K 16/40^(2006.01)
G01N 27/447^(2006.01)

C12N 9/64^(2006.01)
C12P 21/06^(2006.01)
C12Q 1/68^(2006.01)

(86)	International application number:
	PCT/US1999/000603

(87)	International publication number:
	WO 1999/036549 (22.07.1999 Gazette 1999/29)

(54)	TESTIS-SPECIFIC HUMAN SVPH1-8 PROTEINASE TESTISSPEZIFISCHE, MENSCHLICHE PROTEINASE, SVPH1-8 SVPH1-8 PROTEINASE HUMAINE SPECIFIQUE AUX TESTICULES

(84)	Designated Contracting States:
	AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

14.01.1998 US 71505 P

(43)	Date of publication of application:
	25.10.2000 Bulletin 2000/43

(73)	Proprietor: IMMUNEX CORPORATION
	Thousand Oaks, CA 91320-1799 (US)

(72)	Inventor:
	CERRETTI, Douglas, Pat Seattle, WA 98133 (US)

(74)	Representative: Grünecker, Kinkeldey, Stockmair & Schwanhäusser Anwaltssozietät
	Maximilianstrasse 58 80538 München 80538 München (DE)

(56)

References cited: :

WO-A-99/07856

US-A- 5 248 599

HOOFT VAN HUIJSDUIJNEN R: "ADAM 20 and 21;two novel human testis -specific membrane metalloproteases with similarity to fertilin-alpha" GENE, vol. 206, no. 2, 12 January 1998, pages 273-282, XP002088618
New England BioLabs Catalog 96/97 'Protein Molecular Weight MArkers' XP002101692
WOLFSBERG T. G. ET AL.: "ADAM, A NOVEL FAMILY OF MEMBRANE PROTEINS CONTAINING A DISINTEGRIN AND METALLOPROTEASE DOMAIN: MULTIPOTENTIAL FUNCTIONS IN CELL-CELL AND CELL-MATRIX INTERACTIONS" THE JOURNAL OF CELL BIOLOGY, vol. 131, no. 2, October 1995, pages 275-278, XP002046453 cited in the application
EMBL database entry AA758110; accession number AA758110; 26. January 1998; Strausberg R.: 'National Cancer Institute, Cancer Genome Anatomy Project.' XP002101680

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).